Tag

Astrazeneca

All articles tagged with #astrazeneca

healthcare14 days ago•2 min saved

AZ's tozorakimab delivers COPD benefit across populations in Phase 3

AstraZeneca's anti-IL-33 antibody tozorakimab posted positive Phase 3 results in COPD (Oberon and Titania), reducing the annualized rate of moderate-to-severe exacerbations versus placebo in former smokers and showing benefit across the overall population, with a favorable safety profile. The drug’s supposed differentiation comes from complete inhibition of ST2 and RAGE/EGFR signaling, unlike rivals Roche and Sanofi/Regeneron’s IL-33 blockers that produced mixed results. AZ plans to present full data at an upcoming meeting and is pursuing two additional Phase 3 trials (Prospero, Miranda), while maintaining a target of potentially $3–5 billion in peak sales if approved.

via Fierce Biotech|

#astrazeneca #copd #healthcare

business2 months ago•2 min saved

AstraZeneca seals $630M move to own China rights for CAR-T therapy C-CAR031

AstraZeneca will pay up to $630 million to acquire the remaining China rights to its GPC3-targeting CAR-T therapy C-CAR031, giving it full global rights; the deal follows a prior China arrangement and aligns with AZ's push to develop CAR-T therapies for hepatocellular carcinoma, which showed promising early responses in China.

via Fierce Biotech|

#astrazeneca #business #c-car031

health3 months ago•1 min saved

FDA Approves Enhertu and Combo Treatments as First-Line Breast Cancer Therapies

The FDA has approved AstraZeneca and Daiichi Sankyo's drug Enhertu, in combination with Roche's Perjeta, as a first-line treatment for advanced HER2-positive breast cancer, based on a study showing improved progression-free survival and tumor response.

via Reuters|

#astrazeneca #breast-cancer #daiichi-sankyo

healthcare5 months ago•3 min saved

AstraZeneca and Gilead Compete for Leadership in Triple-Negative Breast Cancer Treatments

Major pharmaceutical companies Gilead, AstraZeneca, and Roche reported promising new study results for cancer treatments, particularly in breast cancer, leading to stock price increases for Gilead and AstraZeneca, while Roche's shares declined slightly. The studies highlight advancements in drug efficacy and potential growth in the cancer drug market, with implications for future sales and industry competition.

via TipRanks|

#astrazeneca #breast-cancer #cancer

health5 months ago•1 min saved

AstraZeneca's Datroway Leads in Triple-Negative Breast Cancer Treatment at ESMO

AstraZeneca and Gilead Sciences presented successful trial results for antibody-drug conjugates as new first-line treatments for metastatic triple-negative breast cancer, offering potential options after over a decade without new approvals for this aggressive cancer type.

via statnews.com|

#antibody-drug-conjugate #astrazeneca #breast-cancer

business6 months ago•5 min saved

AstraZeneca and Trump Team Up to Lower Drug Prices

AstraZeneca CEO Pascal Soriot successfully negotiated a significant US medicine deal with President Trump, which included lowering drug prices and establishing a US manufacturing plant, shielding the company from tariffs and boosting its US presence, amid broader US efforts to reduce drug costs and attract pharmaceutical investments.

via Reuters|

#astrazeneca #business #drug-prices

business6 months ago•1 min saved

Trump Announces AstraZeneca Drug Price Reductions

President Trump and AstraZeneca announced a deal to lower drug prices by adopting 'most-favored nation' pricing for Medicaid and new drugs, along with discounts on a government website, while AstraZeneca invests in U.S. manufacturing; the agreement includes a tariff exemption but does not directly reduce prices for Medicare or private insurance, with more deals expected from other drug companies.

via Axios|

#astrazeneca #business #drug-prices

healthcare6 months ago•3 min saved

AstraZeneca and Trump Administration Reach Agreement to Lower Drug Prices

AstraZeneca has agreed to lower drug prices for Medicaid by adopting most-favored-nation pricing, matching the lowest prices in developed countries, as part of a deal with the Trump administration aimed at reducing U.S. prescription drug costs. This follows similar agreements with Pfizer and is part of broader efforts to curb drug prices through executive actions and new government initiatives.

via ABC News - Breaking News, Latest News and Videos|

#astrazeneca #drug-prices #healthcare

politics6 months ago•5 min saved

Trump Announces AstraZeneca Drug Price Reductions

President Donald Trump announced a deal with AstraZeneca to lower prescription drug prices in the US, claiming significant discounts and leveraging tariff threats to secure manufacturing investments and delay tariffs, as part of his broader effort to reduce drug costs and bring manufacturing back to the US.

via Al Jazeera|

#astrazeneca #drug-prices #pharmaceutical-deals

business6 months ago•2 min saved

Trump Announces AstraZeneca Deal to Lower U.S. Drug Prices

AstraZeneca has agreed with the Trump administration to lower drug prices through a deal that includes most-favored-nation pricing for Medicaid and discounts for direct consumer sales, along with expanding manufacturing in the U.S. and receiving tariff exemptions, as part of broader efforts to align U.S. drug prices with those in other developed countries.

via NPR|

#astrazeneca #business #drug-prices

healthcare6 months ago•4 min saved

President Trump Secures New Deal to Lower Drug Prices for Americans

President Trump announced a deal with AstraZeneca to align U.S. drug prices with those of other developed nations, resulting in significant savings for American patients and Medicaid programs, while also investing $50 billion in U.S. pharmaceutical manufacturing and R&D. The agreement includes discounts on key medicines for asthma and COPD, and aims to end the practice of foreign countries subsidizing their healthcare through higher U.S. drug prices.

via The White House (.gov)|

#astrazeneca #drug-pricing #healthcare

business6 months ago•0 min saved

Trump Announces New Drug Price Deal with AstraZeneca

President Donald Trump is set to announce a deal with AstraZeneca to sell its drugs to Medicaid at a discount, marking the second company to agree to the administration's efforts to lower drug prices.

via The Washington Post|

#astrazeneca #business #drug-prices

business6 months ago•1 min saved

Trump Announces Deal with AstraZeneca to Lower U.S. Drug Prices

The Trump administration has reached a deal with AstraZeneca to lower drug prices in the U.S., similar to an earlier agreement with Pfizer, involving selling drugs at the lowest international prices and potentially other incentives, as part of efforts to reduce medication costs and boost U.S. manufacturing investments.

via CNBC|

#astrazeneca #business #drug-prices

business6 months ago•1 min saved

Trump's Pharma Deals and Plans to Lower Drug Prices

President Trump announced an agreement with AstraZeneca to lower drug prices in the U.S., including a 'most-favored-nation' pricing model for low-income Americans, and a $50 billion investment in U.S. drug manufacturing and R&D, with the new pricing website TrumpRx.gov expected to launch in 2026.

via MSNBC News|

#astrazeneca #business #drug-prices

business6 months ago•3 min saved

AstraZeneca Launches $4.5 Billion Manufacturing Hub in Virginia

AstraZeneca plans to invest $4.5 billion to expand its Virginia manufacturing facility near Charlottesville, creating 3,600 jobs and broadening its production scope to include cancer treatments and metabolic medicines, as part of a $50 billion US investment in biotech innovation.

via AstraZeneca US|

#astrazeneca #business #investment